SEC Form 4 · accession 0000899243-19-005256
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas B. Snyder
Officer — Chief Legal Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Feb 26, 2019 | M | 9,612 | $0.0013 | A | 9,612 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 576 | $12.41 | D | 9,036 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 2,400 | $12.42 | D | 6,636 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 1,200 | $12.44 | D | 5,436 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 420 | $12.44 | D | 5,016 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 48 | $12.37 | D | 4,968 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $0.0013 | Feb 26, 2019 | M | 9,612 | D | Feb 26, 2019 | Mar 15, 2020 | Ordinary Shares | 9,612 | 0 | D |
Explanation of responses
- F1Exercise of stock options. Following the exercise, these shares were converted into 801 American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019.
- F3These ordinary shares are represented by ADSs.
- F4The price reported is price per ordinary share converted from price per ADS.